Evidence brief · printable

Atopic Eczema evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Atopic Eczema: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/atopic-eczema.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Dupilumab 4 trials
  • Nemolizumab 4 trials
  • Tacrolimus ointment 3 trials
  • Tralokinumab 3 trials
  • Betamethasone valerate 2 trials
  • Stapokibart (CM310) 2 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Vitamin D 4 trials · 3 completed · 1 with results
  • Care coordination, navigation and outreach 3 trials · 1 completed · 1 with results
  • Probiotics, prebiotics and synbiotics 24 trials · 14 completed · 0 with results
  • Education, coaching and self-management 10 trials · 7 completed · 0 with results
  • Cognitive behavioural and related therapies 5 trials · 4 completed · 0 with results
  • Light and laser therapy (photobiomodulation) 5 trials · 3 completed · 0 with results

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • PRA-216 Atopic Dermatitis Safety and Efficacy Study NCT07810777
  • Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic… NCT06934252
  • A Study Evaluating TRIV-573 in Atopic Dermatitis NCT07782333
  • Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus… NCT07347743
  • AI App for Management of Atopic Dermatitis NCT06362629
  • Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete NCT07444008

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 10 trials of cognitive training and education found, none measured inflammation and other biomarkers 12 trials of other approaches did
  • Among 9 trials of oxygen, light, temperature and manual therapies found, none measured inflammation and other biomarkers 12 trials of other approaches did
  • Among 9 trials of oxygen, light, temperature and manual therapies found, none measured quality of life 9 trials of other approaches did
  • Supplements and nutraceuticals: symptom severity and disease activity 42 trials, no results posted yet
  • Oxygen, light, temperature and manual therapies: symptom severity and disease activity 9 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (112 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.